Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• Independent Bank receives regulatory approval for HCB Financial acquisition